A Deep Learning-Based Classification Method for Different Frequency EEG Data.

In recent years, the research on electroencephalography (EEG) has focused on the feature extraction of EEG signals. The development of convenient and simple EEG acquisition devices has produced a variety of EEG signal sources and the diversity of the EEG data. Thus, the adaptability of EEG classification methods has become significant. This study proposed a deep network model for autonomous learning and classification of EEG signals, which could self-adaptively classify EEG signals with different sampling frequencies and lengths. The artificial design feature extraction methods could not obtain stable classification results when analyzing EEG data with different sampling frequencies. However, the proposed depth network model showed considerably better universality and classification accuracy, particularly for EEG signals with short length, which was validated by two datasets.

AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human Cells.

Recently, it was confirmed that ACE2 is the receptor of SARS-CoV-2, the pathogen causing the recent outbreak of severe pneumonia around the world. It is confused that ACE2 is widely expressed across a variety of organs and is expressed moderately but not highly in lung, which, however, is the major infected organ. Therefore, we hypothesized that there could be some other genes playing key roles in the entry of SARS-CoV-2 into human cells. Here we found that AGTR2 (angiotensin II receptor type 2), a G-protein coupled receptor, has interaction with ACE2 and is highly expressed in lung with a high tissue specificity. More importantly, simulation of 3D structure based protein-protein interaction reveals that AGTR2 shows a higher binding affinity with the Spike protein of SARS-CoV-2 than ACE2 (energy: -8.2 vs. -5.1 [kcal/mol]). A number of compounds, biologics and traditional Chinese medicine that could decrease the expression level of AGTR2 were predicted. Finally, we suggest that AGTR2 could be a putative novel gene for the entry of SARS-CoV-2 into human cells, which could provide different insight for the research of SARS-CoV-2 proteins with their receptors.

Faster R-CNN with improved anchor box for cell recognition.

As the basic units of the human body structure and function, cells have a considerable influence on maintaining the normal work of the human body. In medical diagnosis, cell examination is an important part of understanding the human function. Incorporating cell examination into medical diagnosis would greatly improve the efficiency of pathological research and patient treatment. In addition, cell segmentation and identification technology can be used to quantitatively analyze and study cellular components at the molecular level. It is conducive to the study of the pathogenesis of diseases and to the formulation of highly effective disease treatment programs. However, because cells are of diverse types, their numbers are huge, and they exist in the order of micrometers, detecting and identifying cells without using a deep learning-based computer program are extremely difficult. Therefore, the use of computers to study and analyze cells has a certain practical value. In this work, target detection theory using deep learning is applied to cell detection. A target recognition network model is built based on the faster region-based convolutional neural network (R-CNN) algorithm, and the anchor box is designed in accordance with the characteristics of the data set. Different design methods influence cell detection results. Using the object detection method based on our novel faster R-CNN framework to detect the cell image can help improve the speed and accuracy of cell detection. The method has considerable advantages in dealing with the identification of flowing cells.

Multiswarm Artificial Bee Colony algorithm based on spark cloud computing platform for medical image registration.

BACKGROUND: Over the years, medical image registration has been widely used in various fields. However, different application characteristics, such as scale, computational complexity, and optimization goals, can cause problems. Therefore, developing an optimization algorithm based on clustering calculation is crucial. METHOD: To solve the aforementioned problem, a multiswarm artificial bee colony (MS-ABC) multi-objective optimization algorithm based on clustering calculation is proposed. This algorithm can accelerate the resolution of complex problems on the Spark platform. Experiments show that the algorithm can optimize certain conventional complex problems and perform medical image registration tests. RESULT: Results show that the MS-ABC algorithm demonstrates excellent performance in medical image registration tests. The optimization results of the MS-ABC algorithm for conventional problems are similar to those of existing algorithms; however, its performance is more time efficient for complex problems, especially when additional goals are needed. CONCLUSION: The MS-ABC algorithm is applied to the Spark platform to accelerate the resolution of complex application problems. It can solve the problem of traditional algorithms regarding long calculation time, especially in the case of highly complex and large amounts of data, which can substantially improve data-processing efficiency.

A New Metric Quantifying Chemical and Biological Property of Small Molecule Metabolites and Drugs.

One prominent class of drugs is chemical small molecules (CSMs), but the majority of CSMs are of very low druggable potential. Therefore, it is quite important to predict drug-related properties (druggable properties) for candidate CSMs. Currently, a number of druggable properties (e.g., logP and pKa) can be calculated by in silico methods; still the identification of druggable CSMs is a high-risk task, and new quantitative metrics for the druggable potential of CSMs are increasingly needed. Here, we present normalized bond energy (NBE), a new metric for the above purpose. By applying NBE to the DrugBank CSMs whose properties are largely known, we revealed that NBE is able to describe a number of critical druggable properties including logP, pKa, membrane permeability, blood-brain barrier penetration, and human intestinal absorption. Moreover, given that the human endogenous metabolites can serve as important resources for drug discovery, we applied NBE to the metabolites in the Human Metabolome Database. As a result, NBE showed a significant difference in metabolites from various body fluids and was correlated with some important properties, including melting point and water solubility.

Large-scale in silico identification of drugs exerting sex-specific effects in the heart.

BACKGROUND: Major differences exist between men and women in both physiology and pathophysiology. Dissecting the underlying processes and contributing mechanisms of sex differences in health and disease represents a crucial step towards precision medicine. Considering the significant differences between men and women in the response to pharmacotherapies, our aim was to develop an in silico model able to predict sex-specific drug responses in a large-scale. METHODS: For this purpose, we focused on cardiovascular effects because of their high morbidity and mortality. Our model predicted several drugs (including acebutolol and tacrine) with significant differences in the heart between men and women. To validate the sex-specific drug responses identified by our model, acebutolol was selected to lower blood pressure in spontaneous hypertensive rats (SHR), tacrine was used to assess cardiac injury in mice and metformin as control for a non-sex-specific response. RESULTS: As our model predicted, acebutolol exhibited a stronger decrease in heart rate and blood pressure in female than male SHRs. Tacrine lowered heart rate in male but not in female mice, induced higher plasma cTNI level and increased cardiac superoxide (DHE staining) generation in female than male mice, indicating stronger cardiac toxicity in female than male mice. To validate our model in humans, we employed two Chinese cohorts, which showed that among patients taking a beta-receptor blocker (metoprolol), women reached significantly lower diastolic blood pressure than men. CONCLUSIONS: We conclude that our in silico model could be translated into clinical practice to predict sex-specific drug responses, thereby contributing towards a more appropriate medical care for both men and women.

The DrugPattern tool for drug set enrichment analysis and its prediction for beneficial effects of oxLDL on type 2 diabetes.

Enrichment analysis methods, e.g., gene set enrichment analysis, represent one class of important bioinformatical resources for mining patterns in biomedical datasets. However, tools for inferring patterns and rules of a list of drugs are limited. In this study, we developed a web-based tool, DrugPattern, for drug set enrichment analysis. We first collected and curated 7019 drug sets, including indications, adverse reactions, targets, pathways, etc. from public databases. For a list of interested drugs, DrugPattern then evaluates the significance of the enrichment of these drugs in each of the 7019 drug sets. To validate DrugPattern, we employed it for the prediction of the effects of oxidized low-density lipoprotein (oxLDL), a factor expected to be deleterious. We predicted that oxLDL has beneficial effects on some diseases, most of which were supported by evidence in the literature. Because DrugPattern predicted the potential beneficial effects of oxLDL in type 2 diabetes (T2D), animal experiments were then performed to further verify this prediction. As a result, the experimental evidences validated the DrugPattern prediction that oxLDL indeed has beneficial effects on T2D in the case of energy restriction. These data confirmed the prediction accuracy of our approach and revealed unexpected protective roles for oxLDL in various diseases. This study provides a tool to infer patterns and rules in biomedical datasets based on drug set enrichment analysis. DrugPattern is available at http://www.cuilab.cn/drugpattern.

MicroPattern: a web-based tool for microbe set enrichment analysis and disease similarity calculation based on a list of microbes.

The microbiota colonized on human body is renowned as "a forgotten organ" due to its big impacts on human health and disease. Recently, microbiome studies have identified a large number of microbes differentially regulated in a variety of conditions, such as disease and diet. However, methods for discovering biological patterns in the differentially regulated microbes are still limited. For this purpose, here, we developed a web-based tool named MicroPattern to discover biological patterns for a list of microbes. In addition, MicroPattern implemented and integrated an algorithm we previously presented for the calculation of disease similarity based on disease-microbe association data. MicroPattern first grouped microbes into different sets based on the associated diseases and the colonized positions. Then, for a given list of microbes, MicroPattern performed enrichment analysis of the given microbes on all of the microbe sets. Moreover, using MicroPattern, we can also calculate disease similarity based on the shared microbe associations. Finally, we confirmed the accuracy and usefulness of MicroPattern by applying it to the changed microbes under the animal-based diet condition. MicroPattern is freely available at http://www.cuilab.cn/micropattern.

An analysis of human microbe-disease associations.

The microbiota living in the human body has critical impacts on our health and disease, but a systems understanding of its relationships with disease remains limited. Here, we use a large-scale text mining-based manually curated microbe-disease association data set to construct a microbe-based human disease network and investigate the relationships between microbes and disease genes, symptoms, chemical fragments and drugs. We reveal that microbe-based disease loops are significantly coherent. Microbe-based disease connections have strong overlaps with those constructed by disease genes, symptoms, chemical fragments and drugs. Moreover, we confirm that the microbe-based disease analysis is able to predict novel connections and mechanisms for disease, microbes, genes and drugs. The presented network, methods and findings can be a resource helpful for addressing some issues in medicine, for example, the discovery of bench knowledge and bedside clinical solutions for disease mechanism understanding, diagnosis and therapy.